Immune response in guinea pigs and monkeys to the individual components of a combined diphtheria-pertussis-tetanus antigen plus poliomyelitis vaccine.
作者信息
KENDRICK P L, BROWN G C
出版信息
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 1):473-83. doi: 10.2105/ajph.47.4_pt_1.473.
Abstract
摘要
相似文献
1
Immune response in guinea pigs and monkeys to the individual components of a combined diphtheria-pertussis-tetanus antigen plus poliomyelitis vaccine.
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 1):473-83. doi: 10.2105/ajph.47.4_pt_1.473.
2
Studies on a combined diphtheria-pertussis-tetanus-poliomyelitis vaccine.
Am J Public Health Nations Health. 1960 Mar;50(3 Pt 1):321-8. doi: 10.2105/ajph.50.3_pt_1.321.
3
[STATISTICO-CLINICAL DATA ON THE USE OF THE COMBINED DIPHTHERIA-PERTUSSIS-TETANUS-POLIOVIRUS VACCINE IN INFANTS].
Pediatria (Napoli). 1963;71:962-7.
4
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22.
5
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
Vaccine. 2014 Jun 30;32(31):3942-9. doi: 10.1016/j.vaccine.2014.05.034. Epub 2014 May 19.
6
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.
7
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.
8
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Hum Vaccin Immunother. 2014;10(10):2795-8. doi: 10.4161/21645515.2014.970494.
9
10
DTaP5-HB-IPV-Hib Vaccine (Vaxelis): A Review of its Use in Primary and Booster Vaccination.
Paediatr Drugs. 2017 Feb;19(1):69-80. doi: 10.1007/s40272-016-0208-y.
引用本文的文献
1
Serologic Response of Infants to a Multiple Vaccine for Simultaneous Immunization Against Diphtheria, Pertussis, Tetanus, and Polio-myelitis, in Relation to the Presence of Specific Maternal Antibody.
Am J Public Health Nations Health. 1960 Oct;50(10):1529-38. doi: 10.2105/ajph.50.10.1529.
2
Studies on a combined diphtheria-pertussis-tetanus-poliomyelitis vaccine.
Am J Public Health Nations Health. 1960 Mar;50(3 Pt 1):321-8. doi: 10.2105/ajph.50.3_pt_1.321.
3
HISTORY OF THE ANTIGEN COMMITTEES OF THE AMERICAN PUBLIC HEALTH ASSOCIATION.
Am J Public Health Nations Health. 1965 Sep;55(9):1451-9. doi: 10.2105/ajph.55.9.1451.
4
RESPONSES OF INFANTS TO DTP-P VACCINE USED IN NINE INJECTION SCHEDULES.
Public Health Rep (1896). 1964 Jul;79(7):585-602.
5
[Immunological study of combined antidiphtheritic, antitetanic, antityphoparatyphoid and antipoliomyelitic vaccinaction].
Bull World Health Organ. 1962;26(6):699-725.
6
Multiple antigen for immunization against poliomyelitis, diphtheria, pertussis, and tetanus. II. Response of infants and young children to primary immunization and eighteen-month booster.
Am J Public Health Nations Health. 1959 May;49(5):644-55. doi: 10.2105/ajph.49.5.644.
本文引用的文献
1
Safety and effectiveness of multiple antigen preparations in a group of free-living children.
Am J Public Health Nations Health. 1949 Oct;39(10):1299-1313. doi: 10.2105/ajph.39.10.1299.
2
Multiple Antigens for Active Immunization : Report of the Study Committee on Multiple Antigens, Subcommittee on Evalution of Administrative Practices.
Am J Public Health Nations Health. 1944 May;34(5):452-4. doi: 10.2105/ajph.34.5.452.
3
Simultaneous immunization against diphtheria, tetanus, and pertussis; problems inherent in the production of a good multiple antigen.
Am J Public Health Nations Health. 1950 Jun;40(6):686-90. doi: 10.2105/ajph.40.6.686.
4
Simultaneous immunization of young children against diphtheria, tetanus, and pertussis; experience in a northern metropolitan area.
Am J Public Health Nations Health. 1950 Jun;40(6):681-5. doi: 10.2105/ajph.40.6.681.
5
The effect of inherited antibodies on the active immunization of infants. Part II. Duration of immunity.
J Pediatr. 1951 Dec;39(6):672-5. doi: 10.1016/s0022-3476(51)80230-0.
6
Immune responses and reactions to diphtheria and tetanus toxoids, with pertussis vaccine, aluminum phosphate precipitated.
N Engl J Med. 1950 Sep 21;243(12):442-4. doi: 10.1056/NEJM195009212431204.
7
Evaluation of the 1954 poliomyelitis vaccine field trial; further studies of results determining the effectiveness of poliomyelitis vaccine (Salk) in preventing paralytic poliomyelitis.
J Am Med Assoc. 1955 Aug 6;158(14):1266-70. doi: 10.1001/jama.1955.02960140028004.
8
Vaccination against paralytic poliomyelitis performance and prospects.
Am J Public Health Nations Health. 1955 May;45(5 Pt 1):575-96. doi: 10.2105/ajph.45.5_pt_1.575.
9
Effects of routine immunization of children with triple vaccine (diphtheria-tetanus-pertussis).
Am J Public Health Nations Health. 1955 Mar;45(3):312-8. doi: 10.2105/ajph.45.3.312.
10
Present status of the problem of vaccination against poliomyelitis.
Am J Public Health Nations Health. 1955 Mar;45(3):285-97. doi: 10.2105/ajph.45.3.285.
Zotero 插件